Black and Hispanic individuals—known to be at greater risk of developing the degenerative disease—are significantly less likely than others to show Alzheimer’s pathology on brain scans, according to new research.
A team of healthcare scholars is making U.S. states an offer they hope the border-defined polities won’t refuse: If you’ll pay for the reinvention of primary care, we’ll help sell the public on the rightness of measured, state-level efforts to preserve the profession.
In an email, the Centers for Disease Control and Prevention asked workers to consider supporting screenings of at-risk individuals arriving stateside. The move follows a formal recognition of the ongoing Ebola outbreak in Africa as a Level 2 emergency, meaning the U.S. will have to take certain precautions to keep the virus from entering the country.
Teladoc, the popular telehealth platform, will provide urgent care, dermatology and nutrition support through Walmart’s existing virtual patient care platform. The companies made the announcement Thursday.
Currently, the organization relies on a mobile PET unit that parks once every week. However, demand has grown for PET/CT in the area, rising by around 60% over the last three years alone.
The Bedford, Massachusetts-based company has reportedly been approached about a possible acquisition by competitor Curium Pharma, Bloomberg reported May 22.
Last week hospitals owned by three big health systems filed suit against CVS Health. The trio filed separately, but all accuse the corporation of robbing them of funds they’re owed through the federal 340B drug pricing program.
Quorum Health said the move will allow it to save money through tax exemptions and provide its 11 hospitals with access to the 340B Drug Pricing Program. The health system is majority-owned by Goldentree Asset Management.
The change would represent an imperfect but, in many cases, perfectly appropriate way to oversee the technology without crimping its capabilities. So say three thought leaders who are close watchers of medical ethics and technologies.
Black and Hispanic individuals—known to be at greater risk of developing the degenerative disease—are significantly less likely than others to show Alzheimer’s pathology on brain scans, according to new research.
